이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

자연 환경에서 신경 발달 장애가 있는 아동의 EXPLORER 외골격의 효능 및 유용성

2026년 11월 13일 업데이트: MarsiBionics

Neurodevelopmental disorders often lead to abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as an inability to stand and walk. EXPLORER is a robotic gait exoskeleton designed to rehabilitate children with motor disabilities in home and outdoor environments.

The aim of this study is to evaluate the efficacy and usability of EXPLORER in children with motor disability within their natural settings, including home and community environments.

연구 개요

상태

완전한

개입 / 치료

상세 설명

Neurodevelopmental disorders often lead to abnormal development of the Central Nervous System (CNS), frequently causing motor dysfunctions such as an inability to stand and walk. Robotic devices are a useful tool in the rehabilitation of these children, but most of them are designed to be used in the clinical setting. EXPLORER is a robotic device designed to assist gait in children with motor disability in their homes and the community. The aim of this study is to evaluate the efficacy and usability of EXPLORER in children with motor disability within their natural settings, including home and community environments.

An initial session will be conducted in the participant's natural environment, during which the researchers will instruct the primary caregivers on the use of the device. Subsequently, the device will be left for a two-month period for use in the natural settings deemed appropriate by the family.

연구 유형

중재적

등록 (실제)

20

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Madrid
      • Alcorcón, Madrid, 스페인, 28922
        • Universidad Rey Juan Carlos
      • Madrid, Madrid, 스페인, 28046
        • Hospital Universitario La Paz
      • Madrid, Madrid, 스페인, 28009
        • Hospital Infantil Universitario Niño Jesús-Servicio de Neuro Ortopedia
      • Madrid, Madrid, 스페인, 28007
        • Hospital Universitario Gregorio Marañón
      • Madrid, Madrid, 스페인, 28009
        • Hospital Infantil Universitario Niño Jesús - Servicio de Rehabilitación
      • Madrid, Madrid, 스페인, 28041
        • Hospital Universitario 12 Octubre

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

2년 (어린이)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Diagnosis of any pathology or condition causing neurodevelopmental disorders.
  • Ability to continuously use the device for two weeks, at least 3 times per week, without causing excessive fatigue that would prevent the participant from carrying out their usual activities.
  • Availability and commitment from the family to use the device at least 3 times per week during the planned period, in different environments and with various objectives.
  • Medical authorization for standing, gait training and weight bearing.
  • Informed consent signed by legal guardians.
  • Maximum user weight of 60 kg.
  • Hip width (between greater trochanters) ≤37 cm.
  • Length of the thigh (distance from the greater trochanter to the lateral condyle of the tibia) from 21cm to 36cm.
  • Tibia leg length (distance from the lateral condyle of the tibia to the lateral malleolus) from 20cm to 35cm.
  • Shoe size ≤40 (EU)

Exclusion Criteria:

  • Medical contraindications for standing or walking.
  • Non-reducible contractures or heterotropic ossifications above the degrees allowed by the device or out of the trajectory imposed by the device
  • Spasticity equal to 4 on the Modified Ashworth Scale at the time of use of the device.
  • More than 20º of hip and/or knee non-reducible contractures at the time of using the exoskeleton.
  • Necessity to walk with more than 5º of hip abduction.
  • Impossibility to reach 5º of ankle dorsiflexion with ir without orthoses.
  • Lower length dysmetria that cannot be mitigated with a wedge under the foot.
  • Skin lesion on parts of the lower extremities that are in contact with the device.
  • History of fracture without trauma.
  • Presence of other conditions causing exercise intolerance (such as uncontrolled hypertension, coronary artery disease, arrhythmia, congestive heart failure, severe pulmonary disease).
  • Conductual disorders that may interfere with the use of the device or their participation in the study, like impulsiveness.
  • Allergy to any of the EXPLORER materials: cotton, nylon, polyester, PPS, PEEK or ABS.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: EXPLORER

Two-week period with the robotics gait device for use in the natural settings deemed appropriate by the family.

Two-week period with the robotics gait device for use in the natural settings deemed appropriate by the family.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Serious Adverse Events
기간: through study completion, along 2 weeks

occurrence of any serious adverse event to the participant or the caregiver

through study completion, along 2 weeks
Falls prevalence
기간: through study completion, along 2 weeks

Number of falling events occurred from the participant or caregiver

through study completion, along 2 weeks
Skin integrity
기간: through study completion, along 2 weeks

Occurrence of any injury of the skin in the areas of contact and produced by the use of the device

through study completion, along 2 weeks
Pain (Visual Analogic Scale)
기간: through study completion, along 2 weeks

pain measured by the Visual Analogic Scale (VAS) by the participant and the caregiver, scored from 0 to 10, being 0 "no pain" and 10 "unbearable pain"

through study completion, along 2 weeks
Donning and doffing time
기간: through study completion, along 2 weeks

Time to don and doff the device to each participant

through study completion, along 2 weeks
Device usage time
기간: through study completion, along 2 weeks

Time using the device

through study completion, along 2 weeks
Number of steps
기간: through study completion, along 2 weeks

number of steps with the device

through study completion, along 2 weeks
Usage modes
기간: through study completion, along 2 weeks

two different usage modes (active and automatic).

through study completion, along 2 weeks
Speed
기간: through study completion, along 2 weeks

speed achieved with the device (steps per minute)

through study completion, along 2 weeks
Device accessibility
기간: through study completion, along 2 weeks

Environments where the device has been used and level of accessibility in each environment measured with a 5 points Likert scale (0 not accessible - 5 very accessible)

through study completion, along 2 weeks
Range of motion
기간: Before starting the intervention (S1) and after completing the two weeks of use

Passive Degree to which a joint can move (hip, knee, and ankle joints in both legs). From 0º to 180º.

Before starting the intervention (S1) and after completing the two weeks of use
Participation
기간: Before starting the intervention (S1) and after completing the two weeks of use

Measured with the Child and Adolescent Scale of Participation. 20 ordinal scaled items across 4 subsections.

Maximum total score is 80 (20 items x 4) and the minimum total score is 20 (20 items x 1)

Before starting the intervention (S1) and after completing the two weeks of use

2차 결과 측정

결과 측정
측정값 설명
기간
QUEST
기간: at the end of the intervention

Using the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0) questionnaire administered to the participants' caregivers at the end of the intervention. The QUEST 2.0 scale has 12 items. Each item is rated on a 5-point Likert scale

at the end of the intervention

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 3월 1일

기본 완료 (실제)

2026년 8월 1일

연구 완료 (실제)

2026년 9월 1일

연구 등록 날짜

최초 제출

2024년 12월 20일

QC 기준을 충족하는 최초 제출

2025년 1월 2일

처음 게시됨 (실제)

2025년 1월 9일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 16일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 13일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다